ARTICLE | Company News
Immune Design, Sanofi deal
August 11, 2014 7:00 AM UTC
Immune Design granted Sanofi exclusive rights to discover, develop and commercialize products to treat an undisclosed food allergy using Immune Design’s GLAAS TLR4 agonism discovery platform. Immune ...